Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel T Wilkinson

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Journal of Autism and Developmental Disorders|August 19, 2020
Repetitive and Self-injurious Behaviors in Children with Cornelia de Lange SyndromeSiddharth Srivastava, Bennett Clark, Colleen Landy-Schmitt, et al.
JAMA Psychiatry|May 11, 2022
Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical SettingSina Nikayin, Taeho Greg Rhee, Maria Elena Cunningham, et al.
Psychiatric Services (Washington, D.C.)|May 11, 2021
Barriers to the Implementation of Electroconvulsive Therapy (ECT): Results From a Nationwide Survey of ECT PractitionersSamuel T Wilkinson, Brandon M Kitay, Annie Harper, et al.
Psychotherapy and Psychosomatics|June 29, 2021
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical TrialSamuel T Wilkinson, Taeho Greg Rhee, Jutta Joormann, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2023
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 studyNaim Zaki, Li Nancy Chen, Rosanne Lane, et al.
JAMA Psychiatry|October 19, 2022
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysisTaeho Greg Rhee, Sung Ryul Shim, Brent P Forester, et al.
The American Journal of Psychiatry|October 4, 2017
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-AnalysisSamuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, et al.
Psychiatry Research|April 5, 2023
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal sprayIbrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Journal of Autism and Developmental Disorders|August 19, 2020
Repetitive and Self-injurious Behaviors in Children with Cornelia de Lange SyndromeSiddharth Srivastava, Bennett Clark, Colleen Landy-Schmitt, et al.
JAMA Psychiatry|May 11, 2022
Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical SettingSina Nikayin, Taeho Greg Rhee, Maria Elena Cunningham, et al.
Psychiatric Services (Washington, D.C.)|May 11, 2021
Barriers to the Implementation of Electroconvulsive Therapy (ECT): Results From a Nationwide Survey of ECT PractitionersSamuel T Wilkinson, Brandon M Kitay, Annie Harper, et al.
Psychotherapy and Psychosomatics|June 29, 2021
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical TrialSamuel T Wilkinson, Taeho Greg Rhee, Jutta Joormann, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2023
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 studyNaim Zaki, Li Nancy Chen, Rosanne Lane, et al.
JAMA Psychiatry|October 19, 2022
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysisTaeho Greg Rhee, Sung Ryul Shim, Brent P Forester, et al.
The American Journal of Psychiatry|October 4, 2017
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-AnalysisSamuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, et al.
Psychiatry Research|April 5, 2023
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal sprayIbrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, et al.
Pageof 11